ArticleInvestigational new drugs2020

Tubulin colchicine site binding agent LL01 displays potent antitumor efficiency both in vitro and in vivo with suitable drug-like properties.

Jing-De Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.